Thermo Fisher Scientific announced it is promoting from within for its newly created chief medical officer position.
Dr. Alan Sachs, PhD, who has served as the company's chief scientific officer since 2016, will take on the role. He will be succeeded by Karen Nelson, PhD, who joins the company from a prior position as president of the J. Craig Venter Institute.
Sachs received his medical and doctoral degrees from Stanford Medical School and has decades of experience supporting product development and clinical research in both therapeutics and diagnostics, Thermo Fisher said.
Nelson, a pioneer in the human microbiome field, received a doctoral degree from Cornell University and has authored or co-authored more than 220 peer-reviewed publications, edited three books, and is currently editor in chief of the journals Microbial Ecology and the newly formed PNAS Nexus.
